david amorós prats

Mr. david amorós prats

Barcelona IVI Clinic, Barcelona, Catalonia, Spain

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2021 in Biology
Verified
Journal Article
Open access
PDF file
MJMaría Gil Juliá
María Gil Juliá
IHIrene Hervas
Irene Hervas
AGAna Navarro Gómez-Lechón
Ana Navarro Gómez-Lechón
FQFernando Quintana
Fernando Quintana
DPdavid amorós prats
david amorós prats
NGNicolás Garrido
Nicolás Garrido
The application of MACS non-apoptotic sperm selection in infertility clinics is controversial since the published literature does not agree on its effect on reproductive outcomes. Therefore, it is not part of the routine clinical practice. Classical measures of reproductive success (pregnancy or live birth rates per ovarian stimulation) introduce a bias in the evaluation of a technique’s effect, since only the best embryo is transferred. This retrospective, multicenter, observational study evaluated the impact of MACS on reproductive outcomes, measuring results in classical parameters and cumulative live birth rates (CLBR). Data from ICSI cycles using autologous oocyte in Spanish IVIRMA fertility clinics from January 2008 to February 2020 were divided into two groups according to their semen processing: standard practice (reference: 46,807 patients) versus an added MACS sperm selection (1779 patients). Only when measured as CLBR per embryo transferred and per MII oocyte used was the difference between groups statistically significant. There were no significant differences between MACS and reference groups on pregnancy and live birth rates. In conclusion, results suggest that non-apoptotic sperm selection by MACS on unselected males prior to ICSI with autologous oocytes has limited clinical impact, showing a subtle increase in CLBR per embryo transferred.

2 December 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
ELEvelin E. Lara-Molina
Evelin E. Lara-Molina
JFJason M. Franasiak
Jason M. Franasiak
ADAlmudena Devesa-Peiro
Almudena Devesa-Peiro
MLMarina Lopez-Nogueroles
Marina Lopez-Nogueroles
AVAlberto Vázquez
Alberto Vázquez
PDPatricia Diaz-Gimeno
Patricia Diaz-Gimeno
Background/Objectives: One of the main reasons for discrepancies in the role of vitamin D in ART could be the measurement of the conventional biomarker 25(OH)D3. It is known that this value is affected by multiple factors, such as tissue origin, assay variability, classification criteria, and potential storage-related degradation. In this study, we investigate 24,25(OH)2D3 as a new biomarker to improve vitamin D assessment in women’s reproductive health, particularly regarding oocyte development. Methods: A prospective cohort study including 35 oocyte donors undergoing controlled ovarian stimulation, who were recruited between October and November 2017, was conducted. Vitamin D metabolites were measured at the baseline and after seven months of storage at −80 °C. Paired serum and pooled follicular fluid (FF) samples were collected at oocyte retrieval. 25(OH)D3 and 24,25(OH)2D3 were quantified by ultra-performance liquid chromatography–tandem mass spectrometry (UPLC–MS/MS). Statistical analyses included paired tests (serum vs. FF; baseline vs. stored) and Pearson’s correlations (two-sided α = 0.05). Results: At the baseline, the mean serum 25(OH)D3 concentration was 91.56 ± 39.01 nmol/L and the mean FF concentration was 58.13 ± 19.55 nmol/L (p < 0.0001). Serum 24,25(OH)2D3 averaged 15.62 ± 10.99 nmol/L, compared with 11.26 ± 6.09 nmol/L in FF (p = 0.004). In both fluids, 25(OH)D3 and 24,25(OH)2D3 were strongly correlated (serum R2 = 0.92; FF R2 = 0.91). Across fluids, the serum–FF correlation was stronger for 24,25(OH)2D3 (R2 = 0.77, p <0.0001) than for 25(OH)D3 (R2 = 0.69, p < 0.0001). After seven months of storage, 25(OH)D3 concentrations decreased significantly (serum −32%; FF −38%; both p < 0.0001), whereas 24,25(OH)2D3 levels remained stable (serum p = 0.24; FF p = 0.36). Conclusions: Serum 24,25(OH)2D3 is a more reliable and minimally invasive biomarker for assessing ovarian vitamin D status than the current gold standard, 25(OH)D3. Incorporating this metabolite into research studies and storage quality control may improve the reliability of retrospective analyses based on cryopreserved material, contributing to a better understanding of the role of vitamin D in human reproduction.